---
title: "Long-Term Reintervention and Valve Failure After TAVR: National Real-World Outcomes"
id: "medrxiv-12-long-term-reintervention-clinical-valve-failure-and-outcomes-after"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-12-long-term-reintervention-clinical-valve-failure-and-outcomes-after"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.16.26360543v1?rss=1"
published_at: "2026-08-18T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Long-Term Reintervention and Valve Failure After TAVR: National Real-World Outcomes
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-12-long-term-reintervention-clinical-valve-failure-and-outcomes-after
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.16.26360543v1?rss=1)
- **Published At:** 2026-08-18T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This national retrospective cohort study analyzed 300,927 adults who underwent index **TAVR** between February 2010 and May 2026 using the Epic Cosmos database. - Annual TAVR volume rose more than tenfold between 2016 and 2025; procedural outcomes improved over time. - Thirty-day major adverse cardiovascular events (MACE) fell from 31.8% before 2017 to 18.6% after 2022; 30-day mortality decreased from 3.0% to 1.4% (both P<0.001). - During follow-up 3,315 patients underwent **redo-TAVR** and 347 underwent **surgical explantation** of the transcatheter valve. - Cumulative incidence of aortic valve reintervention was 1.1% at 3 years, 1.2% at 5 years, 1.5% at 7 years, and 2.7% at 10 years; contemporary eras had lower reintervention rates (Gray test, P<0.001). - In propensity-matched comparisons, **redo-TAVR** had lower 30-day mortality, stroke, acute kidney injury, and major bleeding than surgical explantation. - Among propensity-matched hospital survivors, **surgical explantation** was associated with superior long-term survival (hazard ratio 0.64, 95% CI 0.44–0.93; P=0.018). - A prespecified 1-year landmark analysis found that **clinically significant valve failure** requiring repeat intervention occurred earlier after TAVR than after **SAVR**, despite a lower overall cumulative incidence of repeat intervention after TAVR. - Authors conclude that contemporary **TAVR** has improving procedural outcomes and low repeat intervention rates; choice between redo-TAVR and surgical explantation involves trade-offs between perioperative risk and long-term survival. Data and methods (competing-risk analyses, propensity-score matching) were reported; ethics approval was waived by the St Luke’s IRB.
## Clinical Analysis & Structured Key Points
Long-Term Reintervention, Clinical Valve Failure, and Outcomes After Transcatheter Aortic Valve Replacement: A National Real-World Study | medRxiv Skip to main content Long-Term Reintervention, Clinical Valve Failure, and Outcomes After Transcatheter Aortic Valve Replacement: A National Real-World Study View ORCID Profile Zhiyuan Ma , Cyrus P Elmi , Steven M Stevens , Amit Gupta , Peter Puleo , Jamshid Shirani doi: https://doi.org/10.64898/2026.08.16.26360543 Zhiyuan Ma 1 St Luke's University Health Network; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Zhiyuan Ma For correspondence: zhiyuan.ma{at}sluhn.org Cyrus P Elmi 2 Lewis Katz School of Medicine Find this author on Google Scholar Find this author on PubMed Search for this author on this site Steven M Stevens 1 St Luke's University Health Network; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Amit Gupta 1 St Luke's University Health Network; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Peter Puleo 1 St Luke's University Health Network; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jamshid Shirani 1 St Luke's University Health Network; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Background As transcatheter aortic valve replacement (TAVR) expands to younger patients with longer life expectancy, understanding long-term reintervention and clinically significant valve failure has become increasingly important. Objectives To evaluate temporal trends in TAVR outcomes, characterize the incidence and timing of aortic valve reintervention, compare outcomes after redo-TAVR (TAVR-in-TAVR) versus surgical explantation, and assess freedom from clinically significant valve failure requiring repeat intervention after TAVR versus surgical bioprosthetic aortic valve replacement (SAVR). Methods We performed a retrospective cohort study using the Epic Cosmos. Adults undergoing index TAVR between February 2010 and May 2026 were identified. Primary outcomes included aortic valve reintervention and 30-day major adverse cardiovascular events (MACE). Reintervention incidence was estimated using competing-risk methods with death as the competing event. Propensity-score matching compared redo-TAVR with surgical explantation and TAVR with SAVR. A prespecified 1-year landmark analysis evaluated clinically significant valve failure requiring repeat intervention. Results Among 300,927 patients undergoing TAVR, annual procedural volume increased more than tenfold between 2016 and 2025. Thirty-day MACE decreased from 31.8% before 2017 to 18.6% after 2022 (P<0.001), while mortality declined from 3.0% to 1.4% (P<0.001). During follow-up, 3,315 patients underwent redo-TAVR and 347 underwent surgical explantation. The cumulative incidence of reintervention was 1.1%, 1.2%, 1.5%, and 2.7% at 3, 5, 7, and 10 years, respectively, with significantly lower rates in contemporary procedural eras (Gray test, P<0.001). Compared with surgical explantation, redo-TAVR was associated with lower 30-day mortality, stroke, acute kidney injury, and major bleeding. However, among propensity-matched hospital survivors, surgical explantation was associated with superior long-term survival (hazard ratio: 0.64; 95% CI: 0.44 – 0.93; P=0.018). In the landmark analysis, clinically significant valve failure requiring repeat intervention occurred earlier after TAVR than after SAVR despite a lower overall cumulative incidence of repeat intervention following TAVR. Conclusions Contemporary TAVR is associated with progressively improving procedural outcomes and a low incidence of repeat aortic valve intervention. Redo-TAVR offers lower perioperative risk than surgical explantation, whereas surgical explantation is associated with superior long-term survival among selected patients. Earlier clinically significant valve failure requiring repeat intervention after TAVR underscores the importance of lifetime management strategies as TAVR expands to younger populations. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethics committee/IRB of St Luke's University Health Network waived ethical approval for this work (IRB-FY2026-117). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced are available online at https://cosmos.epic.com https://cosmos.epic.com Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Back to top Previous Next Posted August 18, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Long-Term Reintervention, Clinical Valve Failure, and Outcomes After Transcatheter Aortic Valve Replacement: A National Real-World Study Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Long-Term Reintervention, Clinical Valve Failure, and Outcomes After Transcatheter Aortic Valve Replacement: A National Real-World Study Zhiyuan Ma , Cyrus P Elmi , Steven M Stevens , Amit Gupta , Peter Puleo , Jamshid Shirani medRxiv 2026.08.16.26360543; doi: https://doi.org/10.64898/2026.08.16.26360543 Share This Article: Copy Citation Tools Long-Term Reintervention, Clinical Valve Failure, and Outcomes After Transcatheter Aortic Valve Replacement: A National Real-World Study Zhiyuan Ma , Cyrus P Elmi , Steven M Stevens , Amit Gupta , Peter Puleo , Jamshid Shirani medRxiv 2026.08.16.26360543; doi: https://doi.org/10.64898/2026.08.16.26360543 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Cardiovascular Medicine Subject Areas All Articles Addiction Medicine (605) Allergy and Immunology (891) Anesthesia (324) Cardiovascular Medicine (4725) Dentistry and Oral Medicine (473) Dermatology (403) Emergency Medicine (635) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1605) Epidemiology (15741) Forensic Medicine (32) Gastroenterology (1192) Genetic and Genomic Medicine (6932) Geriatric Medicine (723) Health Economics (1045) Health Informatics (4922) Health Policy (1417) Health Systems and Quality Improvement (1720) Hematology (572) HIV/AIDS (1319) Infectious Diseases (except HIV/AIDS) (16203) Intensive Care and Critical Care Medicine (1152) Medical Education (657) Medical Ethics (150) Nephrology (714) Neurology (7112) Nursing (359) Nutrition (1066) Obstetrics and Gynecology (1215) Occupational and Environmental Health (990) Oncology (3552) Ophthalmology (1026) Orthopedics (384) Otolaryngology (440) Pain Medicine (463) Palliative Medicine (138) Pathology (701) Pediatrics (1763) Pharmacology and Therapeutics (729) Primary Care Research (754) Psychiatry and Clinical Psychology (5782) Public and Global Health (9626) Radiology and Imaging (2359) Rehabilitation Medicine and Physical Therapy (1417) Respiratory Medicine (1232) Rheumatology (631) Sexual and Reproductive Health (759) Sports Medicine (571) Surgery (755) Toxicology (106) Transplantation (300) Urology (283)
## Related Clinical Research

- [Preoperative Anemia and Postoperative Outcomes After Cardiac Surgery: Systematic Review and Meta-a](https://medichelpline.com/clinical-feed/medrxiv-12-association-between-preoperative-anemia-and-postoperative-outcomes-in-adults.md)
- [Stress hyperglycemia ratio predicts major complications after cardiac surgery with cardiopulmonary](https://medichelpline.com/clinical-feed/pubmed-42900380.md) (DOI: 10.1007/s00540-026-03921-7)
- [Maternal Vitamin D Status and Preeclampsia Risk in Kenyan Pregnant Women: A Matched Case–Control S](https://medichelpline.com/clinical-feed/plos-one-12-maternal-serum-vitamin-d-levels-and-preeclampsia-among-kenyan-pregnant-women-a.md)
- [Iron-related Parameters and Sepsis-associated Acute Kidney Injury — Source Content Not Available](https://medichelpline.com/clinical-feed/frontiers-in-immunology-19-association-of-iron-related-parameters-with-the-development-of-sepsis.md)
- [SGLT2 Inhibitors and 90-Day Myocardial Infarction Risk After Total Shoulder Arthroplasty](https://medichelpline.com/clinical-feed/pubmed-42012366.md) (DOI: 10.5435/JAAOS-D-25-01211)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.